Post-transplant carfilzomib, lenalidomide, and dexamethasone outperforms post-transplant lenalidomide in multiple myeloma Presented ByDr Dominik Dytfeld, Poznan University of Medical Sciences, Poland TrialPhase 3, ATLAS ConferenceEHA 2022 1 July, 2022 11:24